Literature DB >> 15026196

The potential impact of drug transporters on nucleoside-analog-based antiviral chemotherapy.

P Borst1, J Balzarini, N Ono, G Reid, H de Vries, P Wielinga, J Wijnholds, N Zelcer.   

Abstract

Several ATP-binding cassette (ABC) transporters can transport drugs out of cells against steep concentration gradients resulting in resistance to the drugs transported. Recent work has shown that at least three members of the family of human Multidrug Resistance-associated Proteins (MRPs), MRP4, 5 and 8, are able to transport some nucleoside-monophosphate analogs. This can result in resistance to the base, nucleoside or nucleotide precursors of these results, at least in cell lines with high levels of transporter. The affinity of these transporters for the nucleotide analogs studied thus far is relatively low (millimolar rather than micromolar), and this limits their potential impact on the resistance. We briefly review how ABC transporters in general, and MRPs in particular, could affect the disposition and cellular accumulation of antiviral compounds.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15026196     DOI: 10.1016/j.antiviral.2003.11.002

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  13 in total

Review 1.  The role of transporters in the toxicity of nucleoside and nucleotide analogs.

Authors:  Christopher A Koczor; Rebecca A Torres; William Lewis
Journal:  Expert Opin Drug Metab Toxicol       Date:  2012-04-18       Impact factor: 4.481

Review 2.  Polymeric nanogel formulations of nucleoside analogs.

Authors:  Serguei V Vinogradov
Journal:  Expert Opin Drug Deliv       Date:  2007-01       Impact factor: 6.648

3.  Concentration of nucleosides and related compounds in cerebral and cerebellar cortical areas and white matter of the human brain.

Authors:  Katalin A Kékesi; Zsolt Kovács; Nóra Szilágyi; Mátyás Bobest; Tamás Szikra; Arpád Dobolyi; Gábor Juhász; Miklós Palkovits
Journal:  Cell Mol Neurobiol       Date:  2006-08-01       Impact factor: 5.046

4.  Cellular influx, efflux, and anabolism of 3-carboranyl thymidine analogs: potential boron delivery agents for neutron capture therapy.

Authors:  Elena Sjuvarsson; Vijaya L Damaraju; Delores Mowles; Michael B Sawyer; Rohit Tiwari; Hitesh K Agarwal; Ahmed Khalil; Sherifa Hasabelnaby; Ayman Goudah; Robin J Nakkula; Rolf F Barth; Carol E Cass; Staffan Eriksson; Werner Tjarks
Journal:  J Pharmacol Exp Ther       Date:  2013-09-04       Impact factor: 4.030

Review 5.  Multidrug resistance-associated proteins 3, 4, and 5.

Authors:  Piet Borst; Cornelia de Wolf; Koen van de Wetering
Journal:  Pflugers Arch       Date:  2006-04-04       Impact factor: 3.657

6.  Metabolism, mechanism of action and sensitivity profile of fluorocyclopentenylcytosine (RX-3117; TV-1360).

Authors:  Godefridus J Peters; Kees Smid; Leonardo Vecchi; Ietje Kathmann; Dzjemma Sarkisjan; Richard J Honeywell; Nienke Losekoot; Osnat Ohne; Aric Orbach; Eran Blaugrund; Lak Shin Jeong; Young Bok Lee; Chang-Ho Ahn; Deog Joong Kim
Journal:  Invest New Drugs       Date:  2013-09-19       Impact factor: 3.850

7.  Multidrug resistance-associated protein 9 (ABCC12) is present in mouse and boar sperm.

Authors:  Nobuhito Ono; Ingrid Van der Heijden; George L Scheffer; Koen Van de Wetering; Elizabeth Van Deemter; Marcel De Haas; Arjan Boerke; Bart M Gadella; Dirk G De Rooij; Jacques J Neefjes; Tom A M Groothuis; Lauran Oomen; Lenny Brocks; Toshihisa Ishikawa; Piet Borst
Journal:  Biochem J       Date:  2007-08-15       Impact factor: 3.857

8.  Disruption of cAMP and prostaglandin E2 transport by multidrug resistance protein 4 deficiency alters cAMP-mediated signaling and nociceptive response.

Authors:  Z Ping Lin; Yong-Lian Zhu; Dennis R Johnson; Kevin P Rice; Timothy Nottoli; Bryan C Hains; James McGrath; Stephen G Waxman; Alan C Sartorelli
Journal:  Mol Pharmacol       Date:  2007-10-24       Impact factor: 4.436

9.  Nucleoside map of the human central nervous system.

Authors:  Zsolt Kovács; Arpád Dobolyi; Gábor Juhász; Katalin A Kékesi
Journal:  Neurochem Res       Date:  2009-10-24       Impact factor: 3.996

10.  ABC transporters in cancer: more than just drug efflux pumps.

Authors:  Jamie I Fletcher; Michelle Haber; Michelle J Henderson; Murray D Norris
Journal:  Nat Rev Cancer       Date:  2010-01-15       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.